Modular Medical (MODD) Research & Development (2020 - 2026)

Modular Medical (MODD) has reported Research & Development for 7 consecutive years, with $4.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Research & Development fell 14.86% year-over-year to $4.4 million; the trailing twelve-month figure through Jun 2026 stood at $19.2 million (up 15.54% YoY), and the FY2026 full-year result was $20.0 million, up 35.9% from the prior year.
• Research & Development grew to $4.4 million in Q2 2026 per MODD's latest filing, from $3.8 million in the prior quarter.
• Across five years, Research & Development topped out at $5.6 million in Q3 2025 and bottomed at $2.0 million in Q1 2022.
• Historically, Research & Development has averaged $3.5 million across 5 years, with a median of $3.5 million in 2024.
• The sharpest annual moves came in 2022 and 2026: Research & Development surged 112.86% in 2022, then retreated 14.86% in 2026.
• Over 5 years, Research & Development stood at $2.2 million in 2022, then jumped by 74.69% to $3.8 million in 2023, then climbed by 0.39% to $3.9 million in 2024, then surged by 40.28% to $5.4 million in 2025, then declined by 19.13% to $4.4 million in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $4.4 million, $3.8 million, and $5.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.